Variation and efficacy of scalp cooling in Dutch hospitals among > 5000 breast cancer patients

Background: The population-based Dutch Cancer Registry shows that 60% of patients with breast cancer received chemotherapy and 99% of these treatments are known to introduce severe alopecia. Worldwide scalp cooling is being implemented to prevent chemotherapy-induced alopecia (CIA). FDA clearance has been approved for scalp cooling among breast cancer patients in 2015. It is heading towards standard care as it is added to the NCCN guideline for breast cancer in 2019.

Source: European Journal of Cancer - September 30, 2020 Category: Cancer & Oncology Authors: C. Van Den Hurk, W. Dercksen, B. Vriens, H. Nortier, W. Breed Tags: POSTERS A: Supportive and Palliative Care Including End of Life Treatment Source Type: research